The company, in an exchange to BSE said the plant-1 was inspected by MHRA in December last year.
Pharma company Cipla shares gained more than 4 percent intraday Friday after its flagship product Sereflo has received final approval from the UK health regulator.
CNBC-TV18's Varinder Bansal explains why pharma stocks were buzzing in trade today.
Wockhardt shares rallied nearly 5 percent intraday Wednesday after the approval by UK health regulator to Daman-based facility continued.
"UK MHRA issued a restricted good manufacturing practice certificate, allowing the company to continue manufacture and marketing of critical products for the UK markets," says Mumbai-based Marksans Pharma in its filing.
"The company has undergone recently an inspection at its L1-Chikalthana, Aurangabad manufacturing facility by UK MHRA and have received a communication confirming the closure of the inspection and issuance of an unrestricted GMP certificate," the pharma company said in its filing.
Shares of Wockhardt rallied 5.4 percent intraday Thursday after the US health regulator has not found any issues at Chikalthana plant.
Surajit Pal of Prabhudas Lilladher feels the pharma company's US sales will take atleast 18 months to recover. He fears that if USFDA issue is raised then UK MHRA too may act.